Method making it possible to produce the ideal curvature of a rod of vertebral osteosynthesis material designed to support a patient's vertebral column

Information

  • Patent Grant
  • 12019955
  • Patent Number
    12,019,955
  • Date Filed
    Monday, March 1, 2021
    3 years ago
  • Date Issued
    Tuesday, June 25, 2024
    6 months ago
Abstract
A method and system for producing a curvature of a rod of vertebral osteosynthesis material designed to support a vertebral column of a patient is provided. A production unit receives a model defining the curvature of the rod. The curvature of the rod is based on a pre-operative X-ray of the vertical column and defined by a simulated correction to be applied to the lumbar segment to be treated, a deduced curved segment representing the curvature of the rod based at least in part on one or more of a lumbar lordosis or a first curvature above a repositioned apex point and the second curvature below the repositioned apex point, and a translated curved segment representative of the deduced curve segment being translated away from a mean line of the vertebral column. The production unit uses computer aided design to produce the rod.
Description
FIELD OF THE INVENTION

The present invention relates to a method making it possible to produce the ideal curvature of a rod of vertebral osteosynthesis material designed to support a patient's vertebral column.


BACKGROUND OF THE INVENTION

It is known to analyze a patient's vertebral column in reference to so-called “pelvic” parameters and different morphotypes of a vertebral column, documented in the scientific literature. The appended FIG. 1 very diagrammatically shows the base of the vertebral column, i.e., part of the lumbar vertebrae Land the sacrum S, as well as the femoral heads TF; the aforementioned pelvic criteria are:

    • the SS (sacral slope) criterion, which is the incline angle of the plate of S1 (first vertebra of the sacrum), relative to the horizontal;
    • the PV (pelvic version) criterion, which is the angle formed by the straight segment connecting the center of the femoral heads TF and the center of the plate of S1 with the vertical;
    • the P1 (pelvic incidence) criterion, which is the angle formed by the straight segment connecting the center of the femoral heads TF and the center of the plate of S1 with the perpendicular to the plate of S1.



FIGS. 2A to 2D respectively show:

    • a so-called “type 1” morphotype, in which the apex (i.e., the forwardmost point of the vertebral column) is situated at the median plane of L5 (fifth lumbar vertebra), and the SS criterion corresponds to an angle smaller than 35°;
    • a so-called “type 2” morphotype, in which the apex is situated at the base of L4 (fourth lumbar vertebra), and the SS criterion corresponds to an angle smaller than 35°;
    • a so-called “type 3” morphotype, in which the apex is situated at the median plane of L4, and the SS criterion corresponds to an angle comprised between 35° and 45°;
    • a so-called “type 4” morphotype, in which the apex is situated at the base of L3 (third lumbar vertebra), and the SS criterion corresponds to an angle larger than 45°.


It is accepted that an individual will adopt a natural vertebral column posture, called “economic”, avoiding pain and other pathologies, if his pelvic parameters in particular are in agreement with his back morphotype. If this is not the case, surgical treatment may be considered in order to reestablish proper posture of the vertebral column, in which that agreement exists.


It is well known to perform this type of recovery using rigid vertebral rods, in particular made of metal, fastened to the vertebrae using anchor members such as pedicle screws or laminar hooks, which rods must be curved suitably based on the correction to be done. The publication of patent application No. WO 98/55038 illustrates material of this type.


It has been shown that imparting the appropriate curvature to a straight rod may be very difficult for a surgeon, the curvature being more or less pronounced in any given location of the rod. Currently, such a curvature is done at the surgeon's discretion and calls greatly on the latter's experience and dexterity. The trial and error necessary to obtain an appropriate curvature have the significant drawback of extending the operation time, which is not desirable for the patient, and the risk of implanting a rod with a non-ideal curvature cannot be ruled out.


OBJECTS OF THE INVENTION

The present invention aims to resolve this essential drawback.


The patent application publications No. WO 2004/017836 A2, WO 2009/254326 A 1 and US 2008/079546 A2 describe methods that do not achieve this goal satisfactorily.


SUMMARY OF THE INVENTION

To that end, the method according to the invention comprises the following steps:

    • a) taking a sagittal preoperative x-ray of the vertebral column of the patient to be treated, extending from the cervical vertebrae to the femoral heads;
    • b) on that x-ray, identifying: the so-called “pelvic” parameters, i.e., the sacral slope, the pelvic version and the pelvic incidence,
      • the lumbar lordosis,
      • the position of the apical lumbar vertebra, i.e., that situated furthest forward on the x-ray,
      • at least one of the following measurements:
        • the distance, called SVA, from the vertical of the posterior upper point of the plate of the first vertebra of the sacrum, called S1, to the vertical passing through the center of the 7th cervical vertebra;
        • the distance, called SFD, from the vertical of the posterior upper point of the plate of S1 to the vertical passing through the center of the femoral heads;
        • the angle, called T1/SPI, formed between the segment going from the center of the first dorsal vertebra, called T1, to the center of the femoral heads and the vertical to the center of T1, a cloud of points defining the curvature of the patient's vertebral column, including one point per vertebral level, positioned at the center of the upper plate of an affected vertebra, and a point defining the noted preoperative apex;
    • c) deducing, among predetermined vertebral column morphotypes and from the noted value of the sacral slope, the morphotype to which the treated vertebral column corresponds and deducing the desired postoperative apex point after performing the correction therefrom, and defining the vertebrae in which the anchor members for the vertebral rod to be anchored to the vertebrae will be implanted;
    • d) performing a wire modeling of the patient's vertebral column, for example using CAD software;
    • e) defining, from said pelvic parameters, a reference centered at the plate of S1, the origin point of which is the central point of that plate;
    • f) positioning the different points of said cloud of points, attached to each vertebra, in that reference, and drawing arcs step by step between the identified points, all of the arcs being tangent to each other and the arc extending from S1 being tangent to the straight line perpendicular to the plate of S1;
    • g) reading the values of the arc lengths;
    • h) simulating the correction to be applied to the lumbar segment to be treated as follows:
      • h1) drawing a straight line tangent to the desired postoperative apex point, moving that straight line to a vertical position such that the arc attached to that straight line is tangent to the desired postoperative apex point, the latter thus being repositioned so as to become the apex point of the modeled vertebral column segment,
      • h2) defining, as co-radial to each other, the arcs situated below that apex point and defining as co-radial to each other the arcs situated above that same apex point, so as to obtain two different curvatures, one above that apex point and the other below the apex point,
      • h3) defining the lumbar lordosis as being equal to plus or minus ten degrees of the pelvic incidence, and defining one of the following three values as desired:
        • SVA distance smaller than 5 cm;
        • SVA/SFD ratio comprised between −1.9 and +0.1;
        • the value of this ratio is positive on the side of the vertical of the posterior upper point of the plate of S1 situated toward the femoral heads and is negative on the side of the vertical situated opposite the femoral heads;
        • T1/SPI angle comprised between −9° and 0°, that angle being negative on the side of the vertical at the center of T1 located toward the femoral heads;
      • h4) defining two arcs concentric to the two curvatures obtained during step
      • h2 above, which are tangent to each other at the apex point, those arcs forming a curved segment representing the ideal curvature of the rod to be implanted in order to obtain the correction of the vertebral segment to be treated,
      • h5) translating that curved segment away from the mean line of the vertebral column, over an evaluated mean distance going from the center of the vertebrae to the anchor points of the anchor members for anchoring the rod to the vertebrae of said vertebral segment to be treated, such that the position of said curve segment corresponds to the position the rod will assume once implanted;
      • i) defining the diameter of the rod to be implanted;
      • j) defining a two- or three-dimensional model of the rod, curved along said curve segment, and
      • k) from a straight rod, producing the curvature of that rod according to said model.


Preferably, said predetermined vertebral column morphotypes comprise:

    • a so-called “type 1” morphotype, in which the apex (i.e., the forwardmost point of the vertebral column) is situated at the median plane of L5 (fifth lumbar vertebra), and the SS criterion corresponds to an angle smaller than 35°;
    • a so-called “type 2” morphotype, in which the apex is situated at the base of L4 (fourth lumbar vertebra), and the SS criterion corresponds to an angle smaller than 35°;
    • a so-called “type 3” morphotype, in which the apex is situated at the median plane of L4, and the SS criterion corresponds to an angle comprised between 35° and 45°;
    • a so-called “type 4” morphotype, in which the apex is situated at the base of L3 (third lumbar vertebra), and the SS criterion corresponds to an angle larger than 45°.


Preferably, the two- or three-dimensional modeling done in step j) consists of establishing a drawing or a plan of the rod to be produced.


Preferably, the curvature produced in step k) is done by cold bending.


Preferably, the method comprises, after step h5) or step i) or step j), the transfer of data relative to the rod to be produced to a service provider responsible for producing the curvature of the rod.


Thus, a practitioner, having determined the shape of the rod to be implanted using the method according to the invention, transfers the data relative to the rod to be produced to a service provider responsible for producing the curvature of the rod. Once that curvature is produced, the service provider will deliver the curved rod to the practitioner, who will be able to operate on the patient with his vertebral rod that is ready to be implanted.


The invention will be well understood, and other features and advantages thereof will appear, in reference to the appended diagrammatic drawing, showing, as a non-limiting example, different values used to carry out the method in question and different operations performed in the context of that implementation.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 very diagrammatically shows the base of the vertebral column;



FIG. 2A shows a so-called “type 1” morphotype, in which the apex is situated at the median plane of L5 and the SS criterion corresponds to an angle smaller than 35°;



FIG. 2B shows a so-called “type 2” morphotype, in which the apex is situated at the base of L4 and the SS criterion corresponds to angle smaller than 35°;



FIG. 2C shows a so-called “type 3” morphotype, in which the apex is situated at the median plane of L4 and the SS criterion corresponds to angle comprised between 35° and 45°;



FIG. 2D shows a so-called “type 4” morphotype, in which the apex is situated at the base of L3 and the SS criterion corresponds to angle larger than 45°;



FIG. 3 is a very diagrammatic view of a vertebral column, on which the definition points of an SVA value used to implement the method according to the invention are shown;



FIG. 4 is a view similar to FIG. 3, which shows the definition points of the SVA value and an SFD value, those two values being used to define a ratio employed to carry out the method according to the invention;



FIG. 5 is a view similar to FIG. 3, showing the definition points of a so-called T1/SPI value used to carry out the method according to the invention;



FIGS. 6 to 11 are very diagrammatic views of reference points, segments, arcs of circle and curves used during the different successive steps of this method; and



FIG. 12 is, on the left side of that figure, a view of a drawing or plan P of the curved vertebral rod to be obtained, the shape of which has been defined by the preceding steps of the method and, on the right side of that figure, a view of the curved vertebral rod TV, obtained from that drawing P.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT


FIG. 3 very diagrammatically shows a vertebral column CV, and includes the following information:

    • LL: vertebral segment to be treated;
    • L1, L2, L3, L4, L5, S1, C7: the first, second, third, fourth and fifth lumbar vertebrae, the first vertebra of the sacrum and the seventh cervical vertebra, respectively;
    • Apex: the forward most point of the vertebral column; SS, PV, Pl: the aforementioned pelvic criteria;
    • TF: the femoral heads, shown by a circle;
    • H1 and V1: the horizontal and vertical, respectively, at the posterior upper point of the plate of S1;
    • V2: the vertical passing through the center of the 7th cervical vertebra (C7).



FIG. 4 also mentions a so-called “SFD” value, going from the vertical V1 to the vertical passing through the center of the femoral heads TF.



FIG. 5 also mentions a so-called “T1/SPI” value, which is the angle formed between the T1-TF segment going from the center of the first dorsal vertebra, called T1, to the center of the femoral heads TF and the vertical V3 to the center of T1.


The various steps of the method are illustrated in FIGS. 6 to 11 as follows.



FIG. 6: on a sagittal preoperative x-ray of the vertebral column of the patient to be treated, extending from the cervical vertebrae to the femoral heads, the following are identified:

    • the pelvic parameters,
    • the lumbar lordosis, the position of the apical lumbar vertebra, i.e., that situated furthest forward on the x-ray,
    • as desired, the SVA distance only, or the SVA distance and the SFD distance,
    • a cloud of points defining the curvature of the patient's vertebral column, including one point per vertebral level, positioned at the center of the upper plate of an affected vertebra, and a point defining the noted preoperative apex.


The morphotype to which the treated vertebral column corresponds is deduced on the noted points, among the vertebral column morphotypes shown in FIGS. 2A to 2D, from the value of the noted sacral slope; the desired postoperative apex point after performing the correction is deduced therefrom; the vertebrae in which the anchoring members for the vertebral rod to be anchored to the vertebrae will be implanted are also defined in this step.



FIGS. 7 and 8: a wire model of the vertebral column of the patient is done, for example using CAD software;



FIG. 9: a reference centered at the plate of S1 is defined from said pelvic parameters, the origin point of that reference being the central point of that plate, then the different points of said cloud of points, attached to each vertebra, are positioned in that reference, and arcs between the identified points are drawn step by step, all of the arcs being tangent to each other and the arc extending from S1 being tangent to the straight line perpendicular to the plate of S1;



FIG. 10: the values of the arc lengths are read, and the correction to be applied to the lumbar segment to be treated is simulated as follows:

    • drawing a straight line tangent to the desired postoperative apex point, moving that straight line to a vertical position such that the arc attached to that straight line is tangent to that desired postoperative apex point, the latter thus being repositioned so as to become the apex point of the modeled vertebral column segment,
    • defining, as co-radial to each other, the arcs situated below that apex point and defining, as co-radial to each other, the arcs situated above that same apex point, so as to obtain two different curvatures, one above that apex point and the other below that apex point,
    • defining the lumbar lordosis as being equal to plus or minus ten degrees of the pelvic incidence, and defining, as desired, one of the three following values:
      • SVA distance smaller than 5 cm;
      • SVA/SFD ratio comprised between −1.9 and +0.1; the value of this ratio is positive on the side of the vertical V1 situated toward the femoral heads TF and is negative on the side of that vertical V1 situated opposite the femoral heads TF;
      • T1/SPI angle comprised between −9° and 0 0; this angle is negative on the side of the vertical V3 at the center of T1 located toward the femoral heads TF;
      • defining two arcs concentric to the two curvatures obtained in the above step, which are tangent to each other at the apex point, those arcs forming a curved segment SC representing the ideal curvature of the rod to be implanted in order to obtain the correction of the vertebral segment to be treated.



FIG. 11: the curved segment SC is translated away from the mean line of the vertebral column, over an evaluated mean distance going from the center of the vertebrae to the anchoring points of the anchoring members OA (FIG. 10, it is a pedicle screw) for anchoring the rod to the vertebrae of said vertebral segment to be treated, such that the position of said curve segment SC corresponds to the position that the rod will assume once implanted; the diameter of the rod to be implanted being defined, a two- or three-dimensional model of that rod is then established, curved along said arcs.



FIG. 12: a drawing or plan P is established from that model, then the vertebral rod TV to be obtained is arranged from that drawing P, in particular by cold bending.


The method according to the invention thus has the decisive advantage of making it possible to produce the ideal curvature of a rod for vertebral osteosynthesis material designed to support a patient's vertebral column.

Claims
  • 1. A method for producing a curvature of a rod of vertebral osteosynthesis material designed to support a vertebral column of a patient, the method comprising: receiving, by a production unit, a model defining the curvature of the rod, the curvature of the rod being based on a pre-operative X-ray of the vertical column with a lumbar segment and representative of: a simulated correction to be applied to the lumbar segment to be treated, wherein simulated correction comprises: a repositioned postoperative apex point and a first curvature obtained above the repositioned apex point and a second curvature obtained below the repositioned apex point, anddata representative of a redefined lumbar lordosis;a deduced curved segment representing the curvature of the rod based at least in part on one or more of the defined lumbar lordosis or the first curvature above the repositioned apex point and the second curvature below the repositioned apex point, anda translated curved segment representative of the deduced curve segment being translated away from a mean line of the vertebral column; andproducing the rod by the production unit using computer aided design.
  • 2. The method of claim 1, further comprising: receiving a diameter of the rod.
  • 3. The method of claim 1, wherein the curved segment represents a desired curvature of the rod to be implanted in order to obtain the correction of the lumbar segment to be treated.
  • 4. The method of claim 1, wherein the correction is determined based on at least one measurement in the pre-operative X-ray, the at least one measurement comprises: a SVA distance from a vertical of a posterior upper point of a plate of a first vertebra of a sacrum (S1) to a vertical passing through a center of a seventh cervical vertebra;a SFD distance from the vertical of the posterior upper point of the plate of S1 to a vertical passing through a center of a femoral head; ora T1/SPI angle formed between a segment going from a center of a first dorsal vertebra (T1) to the center of the femoral head and a vertical line extending from the center of T1.
  • 5. The method of claim 4, wherein the at least one measurement is at least one redefined measurement, the at least one redefined measurement comprises: a SVA distance smaller than 5 cm;a SVA/SFD ratio comprised between −1.9 and +0.1 wherein the ratio is positive on the side of the vertical of the posterior upper point of the plate of S1 situated toward the femoral heads and is negative on the side of the vertical situated opposite the femoral heads; ora T1/SPI angle comprised between −9° and 0°, that angle being negative on the side of the vertical at the center of T1 located toward the femoral heads.
  • 6. The method of claim 1, wherein the postoperative apex point is defined by a vertebral column morphotype comprising one or more of: a type 1 morphotype, in which a forwardmost point of the vertebral column is situated at a median plane of L5, and a sacral slope (SS) criterion corresponds to an angle smaller than 35′;a type 2 morphotype, in which the forwardmost point of the vertebral column is situated at a base of L4, and the SS criterion corresponds to an angle smaller than 35′;a type 3 morphotype, in which the forwardmost point of the vertebral column is situated at a median plane of L4, and the SS criterion corresponds to an angle between 35° and 45°; ora type 4 morphotype, in which the forwardmost point of the vertebral column is situated at a base of L3, and the SS criterion corresponds to an angle larger than 45°.
  • 7. The method of claim 1, wherein the producing includes producing the curvature of the by cold bending.
  • 8. The method of claim 1, wherein: the vertebral column extends from a cervical vertebrae to a femoral head a simulated correction; andthe curvature of the rod also being representative of two arcs concentric to the first and second curvatures obtained, which are tangent to each other at the apex point.
  • 9. The method of claim 1, wherein the model is based on a defined vertebrae in which an anchor member for the rod to be anchored to the vertebrae will be implanted.
  • 10. The method of claim 1, wherein the data representative of the redefine lumbar lordosis is equal to plus or minus ten degrees of a pelvic incidence, the pelvic incidence being represented in the pre-operative X-ray as an angle formed by a straight segment connecting a center of a femoral heads and a center of a plate of sacrum (S1) with the perpendicular to the plate of S1.
  • 11. A system for producing a curvature of a rod of vertebral osteosynthesis material designed to support a vertebral column of a patient, the system comprising: a production unit configured to receive data representative of a model defining the curvature of the rod and produce the rod using computer aided design, the curvature of the rod being based on a pre-operative X-ray of the vertical column with a lumbar segment and the model being representative of: a simulated correction to be applied to the lumbar segment to be treated, wherein simulated correction comprises: a repositioned postoperative apex point and a first curvature obtained above the repositioned apex point and a second curvature obtained below the repositioned apex point, anddata representative of lumbar lordosis;a deduced curved segment representing the curvature of the rod based at least in part on one or more of the defined lumbar lordosis or the first curvature above the repositioned apex point and the second curvature below the repositioned apex point, anda translated curved segment representative of the deduced curve segment being translated away from a mean line of the vertebral column,the production unit configured to produce the rod by: defining a diameter of the rod to be implanted based on the received model;defining a three-dimensional plan of the rod based on the received model; andusing a straight rod having the defined diameter, cold bending the straight rod according to the defined three-dimensional plan.
  • 12. The system of claim 11, wherein the curved segment represents a desired curvature of the rod to be implanted in order to obtain the correction of the lumbar segment to be treated.
  • 13. The system of claim 11, wherein the correction is determined based on at least one measurement in the pre-operative X-ray, the at least one measurement comprises: a SVA distance from a vertical of a posterior upper point of a plate of a first vertebra of a sacrum (S1) to a vertical passing through a center of a seventh cervical vertebra;a SFD distance from the vertical of the posterior upper point of the plate of S1 to a vertical passing through a center of a femoral head; ora T1/SPI angle formed between a segment going from a center of a first dorsal vertebra (T1) to the center of the femoral head and a vertical line extending from the center of T1.
  • 14. The system of claim 13, wherein the at least one measurement is at least one redefined measurement, the at least one redefined measurement comprises: a SVA distance smaller than 5 cm;a SVA/SFD ratio comprised between −1.9 and +0.1 wherein the ratio is positive on the side of the vertical of the posterior upper point of the plate of S1 situated toward the femoral heads and is negative on the side of the vertical situated opposite the femoral heads; ora T1/SPI angle comprised between −9° and 0°, that angle being negative on the side of the vertical at the center of T1 located toward the femoral heads.
  • 15. The system of claim 11, wherein the postoperative apex point is defined by a vertebral column morphotype comprising one or more of: a type 1 morphotype, in which a forwardmost point of the vertebral column is situated at a median plane of L5, and a sacral slope (SS) criterion corresponds to an angle smaller than 35′;a type 2 morphotype, in which the forwardmost point of the vertebral column is situated at a base of L4, and the SS criterion corresponds to an angle smaller than 35°;a type 3 morphotype, in which the forwardmost point of the vertebral column is situated at a median plane of L4, and the SS criterion corresponds to an angle between 35° and 45°; ora type 4 morphotype, in which the forwardmost point of the vertebral column is situated at a base of L3, and the SS criterion corresponds to an angle larger than 45°.
  • 16. The system of claim 11, wherein the vertebral column extends from a cervical vertebrae to a femoral head.
  • 17. The system of claim 11, wherein the model is based on a defined vertebrae in which an anchor member for the rod to be anchored to the vertebrae will be implanted.
  • 18. The system of claim 11, wherein the redefine lumbar lordosis is equal to plus or minus ten degrees of a pelvic incidence, the pelvic incidence being represented in the pre-operative X-ray as an angle formed by a straight segment connecting a center of a femoral heads and a center of a plate of sacrum (S1) with the perpendicular to the plate of S1.
Priority Claims (1)
Number Date Country Kind
1358988 Sep 2013 FR national
CROSS-REFERENCE TO RELATED APPLICATION

This application is continuation U.S. serial application Ser. No. 16/389,348, filed Apr. 19, 2019, which is a continuation of U.S. Serial application Ser. No. 14/914,474, filed Feb. 25, 2016, now U.S. Pat. No. 10,318,655, which is a national stage entry of PCT/IB2014/064586 filed Sep. 17, 2014, under the International Convention claiming priority over French Patent Application No. 1358988 filed Sep. 18, 2013, all of which are incorporated herein by reference in their entirely.

US Referenced Citations (481)
Number Name Date Kind
4382438 Jacobs May 1983 A
5006984 Steele Apr 1991 A
5011484 Breard Apr 1991 A
5163440 DeLuca et al. Nov 1992 A
5209752 Ashman et al. May 1993 A
5224035 Yamashita et al. Jun 1993 A
5251127 Raab Oct 1993 A
5291901 Graf Mar 1994 A
5305203 Raab Apr 1994 A
5312405 Korotko et al. May 1994 A
5366455 Dove et al. Nov 1994 A
5413116 Radke et al. May 1995 A
5514180 Heggeness et al. May 1996 A
5609634 Voydeville Mar 1997 A
5667506 Sutterlin Sep 1997 A
5748767 Raab May 1998 A
5785663 Sarvazyan Jul 1998 A
6015409 Jackson Jan 2000 A
6086590 Margulies et al. Jul 2000 A
6213958 Winder Apr 2001 B1
6277120 Lawson Aug 2001 B1
6282437 Franck et al. Aug 2001 B1
6302888 Mellinger et al. Oct 2001 B1
6364849 Wilcox Apr 2002 B1
6385475 Cinquin et al. May 2002 B1
6409684 Wilk Jun 2002 B1
6443953 Perra et al. Sep 2002 B1
6499488 Hunter et al. Dec 2002 B1
6565519 Benesh May 2003 B2
6585666 Suh et al. Jul 2003 B2
6711432 Krause et al. Mar 2004 B1
6716213 Shitoto Apr 2004 B2
6746449 Jones et al. Jun 2004 B2
6786930 Biscup Sep 2004 B2
7066938 Slivka et al. Jun 2006 B2
7338526 Steinberg Mar 2008 B2
7509183 Lin et al. Mar 2009 B2
7534263 Burdulis, Jr. et al. May 2009 B2
7606613 Simon et al. Oct 2009 B2
7611522 Gorek Nov 2009 B2
7618451 Berez et al. Nov 2009 B2
7634119 Tsougarakis et al. Dec 2009 B2
7635367 Groiso Dec 2009 B2
7639866 Pomero et al. Dec 2009 B2
7660623 Hunter et al. Feb 2010 B2
7674293 Kuiper et al. Mar 2010 B2
7715602 Richard May 2010 B2
7763054 Clement et al. Jul 2010 B2
7824413 Varieur et al. Nov 2010 B2
7835778 Foley et al. Nov 2010 B2
7840253 Tremblay et al. Nov 2010 B2
7862593 Clement et al. Jan 2011 B2
7918887 Roche Apr 2011 B2
7953471 Clayton et al. May 2011 B2
7981158 Fitz et al. Jul 2011 B2
7996061 Mollard et al. Aug 2011 B2
7996064 Simon et al. Aug 2011 B2
8000926 Roche et al. Aug 2011 B2
8038716 Duggal et al. Oct 2011 B2
8046050 Govari et al. Oct 2011 B2
8066708 Lang et al. Nov 2011 B2
8077950 Tsougarakis et al. Dec 2011 B2
8083778 Clement et al. Dec 2011 B2
8105330 Fitz et al. Jan 2012 B2
8142842 Sugita et al. Mar 2012 B2
8196825 Turner et al. Jun 2012 B2
8211109 Groiso Jul 2012 B2
8211153 Shaolian et al. Jul 2012 B2
8234097 Steines et al. Jul 2012 B2
8241296 Wasielewski Aug 2012 B2
8246680 Betz et al. Aug 2012 B2
8265790 Amiot et al. Sep 2012 B2
8270253 Roche et al. Sep 2012 B1
8275594 Lin et al. Sep 2012 B2
8308772 Clement et al. Nov 2012 B2
8308775 Clement et al. Nov 2012 B2
8337501 Fitz et al. Dec 2012 B2
8357111 Caillouette et al. Jan 2013 B2
8357166 Aram et al. Jan 2013 B2
8372075 Groiso Feb 2013 B2
8377073 Wasielewski Feb 2013 B2
8394142 Bertagnoli et al. Mar 2013 B2
8398681 Augostino et al. Mar 2013 B2
8400312 Hotokebuchi et al. Mar 2013 B2
8414592 Quirno Apr 2013 B2
8442621 Gorek et al. May 2013 B2
8465527 Clement Jun 2013 B2
8494805 Roche et al. Jul 2013 B2
8506632 Ganem et al. Aug 2013 B2
8532806 Masson Sep 2013 B1
8535337 Chang et al. Sep 2013 B2
8556983 Bojarski et al. Oct 2013 B2
8562653 Alamin et al. Oct 2013 B2
8588892 Hladio et al. Nov 2013 B2
8636776 Rosenberg et al. Jan 2014 B2
8672948 Lemaitre Mar 2014 B2
8685093 Anderson et al. Apr 2014 B2
8690888 Stein et al. Apr 2014 B2
8718820 Amiot et al. May 2014 B2
8740941 Thramann Jun 2014 B2
8758357 Frey Jun 2014 B2
8777877 Stein et al. Jul 2014 B2
8784339 Stein et al. Jul 2014 B2
8801786 Bernard et al. Aug 2014 B2
8814877 Wasielewski Aug 2014 B2
8814915 Hess et al. Aug 2014 B2
8845689 Douget et al. Sep 2014 B2
8852237 Kalfas et al. Oct 2014 B2
8855389 Hoffmann et al. Oct 2014 B1
8864764 Groiso Oct 2014 B2
8870889 Frey Oct 2014 B2
8900316 Lenz et al. Dec 2014 B2
8911448 Stein Dec 2014 B2
8926673 Clement et al. Jan 2015 B2
8945133 Stein et al. Feb 2015 B2
8956416 McCarthy Feb 2015 B2
8974467 Stone Mar 2015 B2
8983813 Miles et al. Mar 2015 B2
8998962 Birch Apr 2015 B2
9011448 Roche et al. Apr 2015 B2
9034037 Fiere et al. May 2015 B2
9039772 Park et al. May 2015 B2
9056017 Kotlus Jun 2015 B2
9066701 Finley et al. Jun 2015 B1
9066734 Schoenefeld et al. Jun 2015 B2
9078755 Mahfouz Jul 2015 B2
9101492 Mangione et al. Aug 2015 B2
9107706 Alamin et al. Aug 2015 B2
9115998 Proulx et al. Aug 2015 B2
9119572 Gorek et al. Sep 2015 B2
9119671 Kast Sep 2015 B2
9125680 Kostrzewski et al. Sep 2015 B2
9144470 Proulx et al. Sep 2015 B2
9168153 Bettenga Oct 2015 B2
9173661 Metzger et al. Nov 2015 B2
9180015 Fitz et al. Nov 2015 B2
9192412 Meyrat et al. Nov 2015 B2
9198678 Frey et al. Dec 2015 B2
9232955 Bonin, Jr. et al. Jan 2016 B2
9233001 Miles et al. Jan 2016 B2
9237952 Kurtz Jan 2016 B2
9248023 Ries et al. Feb 2016 B2
9250620 Kotlus Feb 2016 B2
9278010 Gibson et al. Mar 2016 B2
9283048 Kostrzewski et al. Mar 2016 B2
9289221 Gelaude et al. Mar 2016 B2
9289270 Gielen et al. Mar 2016 B2
9295482 Fitz et al. Mar 2016 B2
9295497 Schoenefeld et al. Mar 2016 B2
9295561 Ball et al. Mar 2016 B2
9301768 Buza et al. Apr 2016 B2
9308050 Kostrzewski et al. Apr 2016 B2
9308091 Lang Apr 2016 B2
9314275 Clement et al. Apr 2016 B2
9314343 Parisi et al. Apr 2016 B2
9320547 Augostino Apr 2016 B2
9320604 Miles et al. Apr 2016 B2
9326780 Wong et al. May 2016 B2
9339277 Jansen et al. May 2016 B2
9345492 Stein et al. May 2016 B2
9358051 Sournac et al. Jun 2016 B2
9358130 Livorsi et al. Jun 2016 B2
9358136 Stein et al. Jun 2016 B2
9364370 Kuhnel Jun 2016 B2
9381085 Axelson, Jr. et al. Jul 2016 B2
9387015 Taylor Jul 2016 B2
9392953 Gharib Jul 2016 B1
9393052 Berg et al. Jul 2016 B2
9402726 Linderman et al. Aug 2016 B2
9408615 Fitz et al. Aug 2016 B2
9408642 Wong et al. Aug 2016 B2
9408698 Miles et al. Aug 2016 B2
9414940 Stein et al. Aug 2016 B2
9433443 Montello et al. Sep 2016 B2
9439659 Schoenefeld et al. Sep 2016 B2
9439767 Bojarski et al. Sep 2016 B2
9439781 Gibson Sep 2016 B2
9445913 Donner et al. Sep 2016 B2
9452022 McIntosh et al. Sep 2016 B2
9452023 Boillot et al. Sep 2016 B2
9452050 Miles et al. Sep 2016 B2
9452064 Trautwein et al. Sep 2016 B2
9468436 Groiso Oct 2016 B2
9468502 Wiebe, III et al. Oct 2016 B2
9491415 Deitz et al. Nov 2016 B2
9492183 Wilkinson et al. Nov 2016 B2
9495483 Steines et al. Nov 2016 B2
9495509 Amiot et al. Nov 2016 B2
9498260 Funk et al. Nov 2016 B2
9504502 Kuiper et al. Nov 2016 B2
9510771 Finley et al. Dec 2016 B1
9510864 Devito Dec 2016 B2
9517134 Lang Dec 2016 B2
9517143 Prevost et al. Dec 2016 B2
9526514 Kelley et al. Dec 2016 B2
9532730 Wasielewski Jan 2017 B2
9539031 Fauth Jan 2017 B2
9539116 Claypool et al. Jan 2017 B2
9539760 Stahl et al. Jan 2017 B2
9547897 Parent et al. Jan 2017 B2
9549782 Park et al. Jan 2017 B2
9554411 Hall et al. Jan 2017 B1
9554910 Vanasse et al. Jan 2017 B2
9561115 Elahinia et al. Feb 2017 B2
9566075 Carroll et al. Feb 2017 B2
9579043 Chien et al. Feb 2017 B2
9585597 McCaulley et al. Mar 2017 B2
9597096 Aghazadeh Mar 2017 B2
9597156 Amiot et al. Mar 2017 B2
9603613 Schoenefeld et al. Mar 2017 B2
9603623 Brooks et al. Mar 2017 B2
9603711 Bojarski et al. Mar 2017 B2
9610086 Park et al. Apr 2017 B2
9615834 Agnihotri et al. Apr 2017 B2
9622712 Munro et al. Apr 2017 B2
9629723 Parisi et al. Apr 2017 B2
9636181 Isaacs May 2017 B2
9642633 Frey et al. May 2017 B2
9649170 Park et al. May 2017 B2
9655729 Parisi et al. May 2017 B2
9662214 Li et al. May 2017 B2
9668748 McKinnon et al. Jun 2017 B2
9668873 Winslow et al. Jun 2017 B2
9675471 Bojarski et al. Jun 2017 B2
9693831 Mosnier et al. Jul 2017 B2
9757072 Urbalejo Sep 2017 B1
9782228 Mosnier et al. Oct 2017 B2
9848922 Tohmeh et al. Dec 2017 B2
9968408 Casey et al. May 2018 B1
9987048 Mosnier et al. Jun 2018 B2
9993177 Chien et al. Jun 2018 B2
10045824 Mosnier et al. Aug 2018 B2
10064656 Mundis, Jr. et al. Sep 2018 B2
10188480 Scholl et al. Jan 2019 B2
10201320 Saget et al. Feb 2019 B2
10219865 Jansen et al. Mar 2019 B2
10314657 Mosnier et al. Jun 2019 B2
10318655 Mosnier et al. Jun 2019 B2
10413365 Mosnier et al. Sep 2019 B1
10420615 Mosnier et al. Sep 2019 B1
10433912 Mosnier et al. Oct 2019 B1
10433913 Mosnier et al. Oct 2019 B2
10441363 Mosnier et al. Oct 2019 B1
10456174 Mickiewicz et al. Oct 2019 B2
10456211 McAfee Oct 2019 B2
20020035321 Bucholz et al. Mar 2002 A1
20020038118 Shoham Mar 2002 A1
20020045812 Ben-Haim et al. Apr 2002 A1
20020068936 Burkus et al. Jun 2002 A1
20020103432 Kawchuk Aug 2002 A1
20030191383 Ben-Haim et al. Oct 2003 A1
20030204189 Cragg Oct 2003 A1
20040120781 Luca et al. Jun 2004 A1
20040143243 Wahrburg Jul 2004 A1
20040152972 Hunter Aug 2004 A1
20040167637 Biscup Aug 2004 A1
20040171924 Mire et al. Sep 2004 A1
20040172020 Beaurain et al. Sep 2004 A1
20040215190 Nguyen et al. Oct 2004 A1
20040243148 Wasielewski Dec 2004 A1
20040267279 Casutt et al. Dec 2004 A1
20050149050 Stifter et al. Jul 2005 A1
20050177239 Steinberg Aug 2005 A1
20050182320 Stifter et al. Aug 2005 A1
20050182454 Gharib et al. Aug 2005 A1
20050203531 Lakin et al. Sep 2005 A1
20050203532 Ferguson Sep 2005 A1
20050262911 Dankowicz et al. Dec 2005 A1
20060015018 Jutras et al. Jan 2006 A1
20060015030 Poulin et al. Jan 2006 A1
20060036259 Carl et al. Feb 2006 A1
20060069324 Block et al. Mar 2006 A1
20060074431 Sutton Apr 2006 A1
20060136058 Pietrzak Jun 2006 A1
20060142657 Quaid et al. Jun 2006 A1
20060285991 McKinley Dec 2006 A1
20060287627 Johnson Dec 2006 A1
20070021682 Gharib et al. Jan 2007 A1
20070118243 Schroeder et al. May 2007 A1
20070173818 Hestad et al. Jul 2007 A1
20070225731 Couture et al. Sep 2007 A1
20080009866 Alamin et al. Jan 2008 A1
20080058945 Hajaj et al. Mar 2008 A1
20080108991 von Jako May 2008 A1
20080177203 von Jako Jul 2008 A1
20080245972 Drapeau Oct 2008 A1
20080255575 Justis et al. Oct 2008 A1
20080262549 Bennett et al. Oct 2008 A1
20080281332 Taylor Nov 2008 A1
20090024164 Neubardt Jan 2009 A1
20090076615 Duggal et al. Mar 2009 A1
20090194206 Jeon et al. Aug 2009 A1
20090204159 Justis et al. Aug 2009 A1
20090248080 Wilcox et al. Oct 2009 A1
20090249851 Isaacs Oct 2009 A1
20090254326 Isaacs Oct 2009 A1
20090264932 Alamin et al. Oct 2009 A1
20100042157 Trieu Feb 2010 A1
20100100011 Roche Apr 2010 A1
20100191071 Anderson et al. Jul 2010 A1
20100191088 Anderson et al. Jul 2010 A1
20100217270 Polinski et al. Aug 2010 A1
20100217336 Crawford et al. Aug 2010 A1
20110004309 Holm Jan 2011 A9
20110071802 Bojarski et al. Mar 2011 A1
20110106163 Hochschuler et al. May 2011 A1
20110118740 Rabiner et al. May 2011 A1
20110137345 Stoll et al. Jun 2011 A1
20110172566 Kawchuk Jul 2011 A1
20110214279 Park et al. Sep 2011 A1
20110224796 Weiland et al. Sep 2011 A1
20110257653 Hughes et al. Oct 2011 A1
20110257657 Turner et al. Oct 2011 A1
20110295159 Shachar et al. Dec 2011 A1
20110295378 Bojarski et al. Dec 2011 A1
20110306873 Shenai et al. Dec 2011 A1
20120022357 Chang et al. Jan 2012 A1
20120035611 Kave Feb 2012 A1
20120123301 Connor et al. May 2012 A1
20120143090 Hay et al. Jun 2012 A1
20120150243 Crawford et al. Jun 2012 A9
20120165872 Alamin et al. Jun 2012 A1
20120172884 Zheng et al. Jul 2012 A1
20120203289 Beerens et al. Aug 2012 A1
20130079678 Stein et al. Mar 2013 A1
20130079679 Roche et al. Mar 2013 A1
20130079790 Stein et al. Mar 2013 A1
20130131486 Copf et al. May 2013 A1
20130211531 Steines et al. Aug 2013 A1
20130245631 Bettenga Sep 2013 A1
20130253599 Gorek et al. Sep 2013 A1
20130268007 Rezach et al. Oct 2013 A1
20130303883 Zehavi et al. Nov 2013 A1
20130345718 Crawford et al. Dec 2013 A1
20140058407 Tsekos et al. Feb 2014 A1
20140100579 Kelman et al. Apr 2014 A1
20140135658 Hladio et al. May 2014 A1
20140180415 Koss Jun 2014 A1
20140194889 Chang et al. Jul 2014 A1
20140228670 Justis et al. Aug 2014 A1
20140228860 Steines et al. Aug 2014 A1
20140244220 McKinnon et al. Aug 2014 A1
20140257402 Barsoum Sep 2014 A1
20140272881 Barsoum Sep 2014 A1
20140277149 Rooney et al. Sep 2014 A1
20140296860 Stein et al. Oct 2014 A1
20140303672 Tran et al. Oct 2014 A1
20140316468 Keiser et al. Oct 2014 A1
20150057756 Lang et al. Feb 2015 A1
20150066145 Rogers et al. Mar 2015 A1
20150080901 Stein Mar 2015 A1
20150081029 Bojarski et al. Mar 2015 A1
20150088030 Taylor Mar 2015 A1
20150100066 Kostrzewski et al. Apr 2015 A1
20150100091 Tohmeh et al. Apr 2015 A1
20150105782 D'Lima et al. Apr 2015 A1
20150127055 Dvorak et al. May 2015 A1
20150150646 Pryor et al. Jun 2015 A1
20150164657 Miles et al. Jun 2015 A1
20150182292 Hladio et al. Jul 2015 A1
20150223900 Wiebe, III et al. Aug 2015 A1
20150245844 Kennedy et al. Sep 2015 A1
20150250597 Lang et al. Sep 2015 A1
20150265291 Wilkinson Sep 2015 A1
20150305878 O'Neil et al. Oct 2015 A1
20150305891 Bergin et al. Oct 2015 A1
20150313723 Jansen et al. Nov 2015 A1
20150328004 Mafhouz Nov 2015 A1
20150366630 Gorek et al. Dec 2015 A1
20160000571 Mahfouz Jan 2016 A1
20160007983 Frey et al. Jan 2016 A1
20160015465 Steines et al. Jan 2016 A1
20160022176 Le Huec et al. Jan 2016 A1
20160022370 Pavlovskaia et al. Jan 2016 A1
20160038161 Gibson Feb 2016 A1
20160038238 Kostrzewski et al. Feb 2016 A1
20160038242 Lo Iacono et al. Feb 2016 A1
20160038293 Slamin et al. Feb 2016 A1
20160038307 Bettenga Feb 2016 A1
20160045230 Lowery et al. Feb 2016 A1
20160045317 Lang et al. Feb 2016 A1
20160045326 Hansen et al. Feb 2016 A1
20160058320 Chien et al. Mar 2016 A1
20160058523 Chien et al. Mar 2016 A1
20160074052 Keppler et al. Mar 2016 A1
20160074202 Reed et al. Mar 2016 A1
20160081754 Kostrzewski et al. Mar 2016 A1
20160095710 Juszczyk et al. Apr 2016 A1
20160100907 Gomes Apr 2016 A1
20160106483 Mayer et al. Apr 2016 A1
20160128847 Kurtaliaj et al. May 2016 A1
20160143744 Bojarski et al. May 2016 A1
20160157751 Mahfouz Jun 2016 A1
20160199101 Sharifi-Mehr et al. Jul 2016 A1
20160228192 Jansen et al. Aug 2016 A1
20160235447 Mundis, Jr. et al. Aug 2016 A1
20160235480 Scholl et al. Aug 2016 A1
20160235493 LeBoeuf, II et al. Aug 2016 A1
20160242819 Simpson et al. Aug 2016 A1
20160242857 Scholl Aug 2016 A1
20160242934 van der Walt et al. Aug 2016 A1
20160256279 Sanders et al. Sep 2016 A1
20160256285 Jansen Sep 2016 A1
20160262800 Scholl et al. Sep 2016 A1
20160262895 Shea et al. Sep 2016 A1
20160270802 Fang et al. Sep 2016 A1
20160270931 Trieu Sep 2016 A1
20160274571 Lavallee et al. Sep 2016 A1
20160283676 Lyon et al. Sep 2016 A1
20160287395 Khalili et al. Oct 2016 A1
20160296285 Chaoui et al. Oct 2016 A1
20160310221 Bar et al. Oct 2016 A1
20160331417 Trautwein et al. Nov 2016 A1
20160354009 Schroeder Dec 2016 A1
20160354161 Deitz Dec 2016 A1
20160360997 Yadav et al. Dec 2016 A1
20170000568 O'Neil et al. Jan 2017 A1
20170007145 Gharib et al. Jan 2017 A1
20170007328 Cattin et al. Jan 2017 A1
20170007408 Fitz et al. Jan 2017 A1
20170027590 Amiot et al. Feb 2017 A1
20170027617 Strnad Feb 2017 A1
20170035580 Murphy Feb 2017 A1
20170056179 Lorio Mar 2017 A1
20170056196 Kuiper et al. Mar 2017 A1
20170071503 Wasielewski Mar 2017 A1
20170119472 Herrmann et al. May 2017 A1
20170132389 McCaulley et al. May 2017 A1
20170135706 Frey et al. May 2017 A1
20170135707 Frey et al. May 2017 A9
20170135770 Scholl et al. May 2017 A1
20170143426 Isaacs et al. May 2017 A1
20170143494 Mahfouz May 2017 A1
20170143502 Yadin et al. May 2017 A1
20170156798 Wasielewski Jun 2017 A1
20170189121 Frasier et al. Jul 2017 A1
20170231661 Bannigan et al. Aug 2017 A1
20170231709 Gupta et al. Aug 2017 A1
20170252107 Turner et al. Sep 2017 A1
20170273718 Metzger et al. Sep 2017 A1
20170360493 Zucker et al. Dec 2017 A1
20180078286 Le Couedic et al. Mar 2018 A1
20180178148 Mazor et al. Jun 2018 A1
20180256067 Chien et al. Sep 2018 A1
20180289396 McGahan et al. Oct 2018 A1
20180295584 Gliner et al. Oct 2018 A1
20180301213 Zehavi et al. Oct 2018 A1
20180303552 Ryan et al. Oct 2018 A1
20180310993 Hobeika et al. Nov 2018 A1
20190015136 Kraemer Jan 2019 A1
20190029733 Mickiewicz et al. Jan 2019 A1
20190046269 Hedblom et al. Feb 2019 A1
20190046287 Fallin et al. Feb 2019 A1
20190059951 Barrus Feb 2019 A1
20190060086 Krause et al. Feb 2019 A1
20190069956 Ryan et al. Mar 2019 A1
20190083144 Sharifi-Mehr et al. Mar 2019 A1
20190099221 Schmidt et al. Apr 2019 A1
20190103190 Schmidt et al. Apr 2019 A1
20190110819 Triplett et al. Apr 2019 A1
20190117278 Chin Apr 2019 A1
20190122364 Zhang et al. Apr 2019 A1
20190142599 Thibodeau May 2019 A1
20190167314 Mosnier et al. Jun 2019 A1
20190201013 Siccardi et al. Jul 2019 A1
20190201155 Gupta et al. Jul 2019 A1
20190216507 Bannigan et al. Jul 2019 A1
20190223916 Barrus et al. Jul 2019 A1
20190231435 Zucker et al. Aug 2019 A1
20190231443 McGinley et al. Aug 2019 A1
20190231557 Sutterlin, III et al. Aug 2019 A1
20190239935 Willis et al. Aug 2019 A1
20190247100 Mundis, Jr. et al. Aug 2019 A1
20190254719 Gandhi et al. Aug 2019 A1
20190262015 Siccardi et al. Aug 2019 A1
20190269463 Mosnier et al. Sep 2019 A1
20190380782 McAfee et al. Dec 2019 A1
20200060768 Mosnier et al. Feb 2020 A1
20200121394 Mosnier et al. Apr 2020 A1
20200170676 Grob Jun 2020 A1
20200315708 Mosnier et al. Oct 2020 A1
Foreign Referenced Citations (108)
Number Date Country
2015258176 Dec 2015 AU
2015202416 Mar 2017 AU
2019200740 Feb 2019 AU
2019200888 Feb 2019 AU
2014363945 Apr 2019 AU
2019203557 Jun 2019 AU
2872845 Nov 2013 CA
2927955 Apr 2014 CA
1816134 Aug 2006 CN
102805677 Dec 2012 CN
104127229 Nov 2014 CN
205073000 Mar 2016 CN
103892953 May 2016 CN
104323843 Jan 2017 CN
104434287 Jan 2017 CN
105078555 Sep 2018 CN
1 570 781 Sep 2005 EP
2 053 580 Apr 2009 EP
2 749 235 Jul 2014 EP
2 754 419 Jul 2014 EP
2 496 183 Sep 2015 EP
3 000 443 Mar 2016 EP
2 608 749 Aug 2016 EP
2 403 434 Apr 2017 EP
3 395 281 Oct 2018 EP
3 431 032 Jan 2019 EP
1358988 Apr 1964 FR
1360208 May 1964 FR
2016-537036 Dec 2016 JP
2016-540610 Dec 2016 JP
1497721 Jul 1989 SU
1704102 Jan 1992 SU
9855038 Dec 1998 WO
0053077 Sep 2000 WO
04017836 Mar 2004 WO
04030559 Apr 2004 WO
04089224 Oct 2004 WO
04111948 Dec 2004 WO
05074368 Aug 2005 WO
06075331 Jul 2006 WO
06084193 Aug 2006 WO
07035925 Mar 2007 WO
07038290 Apr 2007 WO
08002588 Jan 2008 WO
08079546 Jul 2008 WO
08124079 Oct 2008 WO
09119181 Oct 2009 WO
09124245 Oct 2009 WO
10044880 Apr 2010 WO
10064234 Jun 2010 WO
10121147 Oct 2010 WO
10147972 Dec 2010 WO
11021192 Feb 2011 WO
12012863 Feb 2012 WO
12113030 Aug 2012 WO
12131660 Oct 2012 WO
13003435 Jan 2013 WO
14191790 Dec 2014 WO
15040552 Mar 2015 WO
15054543 Apr 2015 WO
15056131 Apr 2015 WO
15079011 Jun 2015 WO
15089118 Jun 2015 WO
15185219 Dec 2015 WO
15195843 Dec 2015 WO
15200720 Dec 2015 WO
16012726 Jan 2016 WO
16019424 Feb 2016 WO
16019425 Feb 2016 WO
16019426 Feb 2016 WO
1626053 Feb 2016 WO
16032875 Mar 2016 WO
16044352 Mar 2016 WO
16048800 Mar 2016 WO
16088130 Jun 2016 WO
16094826 Jun 2016 WO
16102026 Jun 2016 WO
16137347 Sep 2016 WO
16148675 Sep 2016 WO
16165030 Oct 2016 WO
17001851 Jan 2017 WO
17039596 Mar 2017 WO
17064719 Apr 2017 WO
17066518 Apr 2017 WO
17077356 May 2017 WO
17079655 May 2017 WO
17127838 Jul 2017 WO
17151949 Sep 2017 WO
17221257 Dec 2017 WO
18045086 Mar 2018 WO
18055494 Mar 2018 WO
18055518 Mar 2018 WO
18078636 May 2018 WO
18087758 May 2018 WO
18131044 Jul 2018 WO
18131045 Jul 2018 WO
18183314 Oct 2018 WO
18185755 Oct 2018 WO
18193316 Oct 2018 WO
18193317 Oct 2018 WO
18203101 Nov 2018 WO
2019014452 Jan 2019 WO
2019036039 Feb 2019 WO
2019043426 Mar 2019 WO
2019068085 Apr 2019 WO
2019070729 Apr 2019 WO
2019118844 Jun 2019 WO
2019140240 Jul 2019 WO
Non-Patent Literature Citations (23)
Entry
Aurouer, N., Obeid, I., Gille, O., Pointillart, V., & Vital, J. M. (2009). Computerized preoperative planning for correction of sagittal deformity of the spine. Surgical and radiologic anatomy, 31, 781-792. (Year: 2009).
Aurouer et al. “Computerized preoperative planning for correction of sagittal deformity of the spine”, Surg Radiol Anat 31, 2009, pp. 781-792. (Year: 2009).
Abe et al. “Scoliosis corrective force estimation from the implanted rod deformation using 3 D FEM analysis”, 2015, Scoliosis 10(Suppl 2):52, 6 pages.
Aubin et al. “Preoperative Planning Simulator for Spinal Deformity Surgeries”, Spine 2008, 33(20):2143-2152.
Reinshagen et al. “A novel minimally invasive technique for lumbar decompression, realignment, and navigated interbody fusion”, J Clin Neurosci. 2015, 22(9):1484-1490: XP055503028.
Rickert et Al., “Posterior lumbar interbody fusion implants”, Orthopaede. Springer Verlag, Berlin, DE vol. 44, No. 2 dated Jan. 28, 2015 pp. 162-169.
Spontech Medical AG Vertaplan—die Software fiir Wirbelsaulenchirurgen, Aug. 29, 2013 Retrieved from the Internet: URL: <https://www.youtube.com/watch?v=q0qhW1T1cp8> in 1 page.
Barton et al., Mar./Apr. 2016, Early experience and initial outcomes with patient-specific spine rods for adult spinal deformity, Trending in Orthopedics, 39(2):79-86.
Fiere et al., Jul. 2016, 40. Preoperative planning and patient-specific rods for surgical treatment of thoracolumbar sagittal imbalance, in Surgery of the Spine and Spinal Cord. A Neurosurgical Approach, Van de Kalft ed., Springer International Publishing, Switzerland, pp. 645-662.
Foroozandeh et al., Summer 2012, 3D reconstruction using cubic Bezier spline curves and active contours (case study), Iranian Journal of Medical Physics, 9(3):169-176.
Galbusera et al., Feb. 2019, Artificial intelligence and machine learning in spine research, JOR Spine, 2:E1044, 20 pp.
Grove, 2011, Heterogeneous modeling of medical image data using B-spline functions, doctoral dissertation, Department of Computer Science and Engineering, University of South Florida, 212 pp.
Lazarus, Jun. 21, 2013, An introduction to splines, 29 pp.
Li et al., 2009, Modeling and measurement of 3D deformation of scoliotic spine using 2D x-ray images, Lecture Notes in Computer Science, 8 pp.
Lin, Sep. 17-21, 2003, The simplified spine modeling by 3-D Bezier curve based on the orthogonal spinal radiographic images, Proceedings of the 25th Annual International Conference of the IEEE EMBS, Cancun, Mexico, pp. 944-946.
Pasha et al., 2018, Data-driven classification of the 3D spinal curve in adolescent idiopathic scoliosis with an applications in surgical outcome prediction, Scientific Reports, 8:16296, 10 pp.
Poredos et al., 2015, Determination of the human spine curve based on laser triangulation, BMC Medical Imaging 15(2):1-11.
Prautzsch et al., Mar. 26, 2001, Bezier-and B-spline techniques, 58 pp.
Ratnakar et al. 2011, Predicting thoracic spinal postures in finite element model with Bezier technique, Ircobe Conference 2011, IRC-11-57, 4 pp.
Solla et al., Mar. 2019, Patient-specific rods for surgical correction of sagittal imbalance in adults: Technical aspects and preliminary results: Clin Spine Surg, 32(2): 7 pp.
International Search Report in PCT Application PCT/IB2014/064586, dated Dec. 23, 2014, in 2 pages.
International Search Report in POT Application PCT/US2016/060676, dated Nov. 5, 2017 in 7 pages.
International Search Report and Written Opinion in PCT Application PCT/IB2018/000551, dated Dec. 12, 2018 in 9 pages.
Related Publications (1)
Number Date Country
20210216671 A1 Jul 2021 US
Continuations (2)
Number Date Country
Parent 16389348 Apr 2019 US
Child 17188261 US
Parent 14914474 US
Child 16389348 US